PLGA Nanoparticles for Ultrasound-Mediated Gene Delivery to Solid Tumors
Figure 7
. Echogenic PLGA nanoparticles can be utilized also as ultrasound contrast agents in vivo. (a) (1) A tumor image obtained with the high-resolution ultrasound system VEVO770 (VisualSonics). (2) Kinetics of the contrast agent in the whole tumor shown in (1). (b) (3) Kinetics of the contrast agent in the central area of the tumor shown in (1). (4) Kinetics of the PLGA nanoparticles in the whole tumor shown in (1).
